Principle of Enzyme Diagnosis in Myocardial Infarction


 1. The core principle is that **damaged or dying cardiac cells release their intracellular enzymes and proteins into the bloodstream**, so measuring these biomarkers in blood indirectly detects myocardial injury.

2. An ideal diagnostic marker should be **cardiac-specific, released early, rise and fall in a predictable pattern, remain detectable long enough, and be easy to measure accurately**.

3. **Cardiac troponins (cTnI and cTnT)** are the preferred markers because they are largely unique to heart muscle, giving them very high specificity for myocardial damage.

4. Diagnosis relies on **kinetics**—each marker has a characteristic rise, peak, and return to baseline, so the timing of the blood draw relative to symptom onset matters greatly.

5. Because a single value can be misleading, **serial measurements** (repeat testing over hours) are used to detect a significant rise or fall (delta change), which helps distinguish acute injury from chronic elevation.

6. **High-sensitivity troponin assays** allow rapid rule-in/rule-out protocols by detecting tiny amounts of the marker very early after injury.

7. **CK-MB**, with its shorter half-life and faster normalization, remains useful for detecting **re-infarction**, since a new rise can be identified after a previous infarct.

8. Enzyme results must always be interpreted **together with clinical symptoms, ECG changes, and imaging**, because elevated markers alone do not prove that the injury is due to an acute coronary thrombosis.

0 Comments